LOSORDO DOUGLAS W 4
4 · CALADRIUS BIOSCIENCES, INC. · Filed Jun 21, 2018
Insider Transaction Report
Form 4
LOSORDO DOUGLAS W
Chief Medical Officer
Transactions
- Award
Common Stock
2018-06-20$8.64/sh+13,300$114,912→ 100,389 total - Tax Payment
Common Stock
2018-06-20$8.64/sh−6,407$55,356→ 93,982 total
Footnotes (2)
- [F1]Reflects 13,300 in performance rights, the criteria for which was satisfied on April 6, 2018 and which vested in full on June 20, 2018, when the shareholders voted to approve the new 2018 Equity Incentive Compensation Plan.
- [F2]Includes 42,763 shares of unvested restricted stock.